Therapeutic strategies for congenital myasthenic syndromes
To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...
Glavni autori: | Lee, M, Beeson, D, Palace, J |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Wiley
2018
|
Slični predmeti
-
The congenital myasthenic syndromes.
od: Palace, J, i dr.
Izdano: (2008) -
Congenital myasthenic syndromes.
od: Beeson, D, i dr.
Izdano: (1997) -
Congenital myasthenic syndromes: an update.
od: Finlayson, S, i dr.
Izdano: (2013) -
Congenital myasthenic syndromes and the neuromuscular junction.
od: Cruz, P, i dr.
Izdano: (2014) -
The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
od: Rodríguez Cruz, P, i dr.
Izdano: (2018)